{"id":"https://openalex.org/W2892242588","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e17036","title":"Novel formulation of abiraterone acetate with significantly higher bioavailability and eliminated food effect might allow higher abiraterone exposure and better patient outcome.","display_name":"Novel formulation of abiraterone acetate with significantly higher bioavailability and eliminated food effect might allow higher abiraterone exposure and better patient outcome.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2892242588","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e17036","mag":"2892242588"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.e17036","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e17036","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e17036","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013293839","display_name":"Hristos Glavinas","orcid":"https://orcid.org/0000-0003-4785-2713","observed_orcids":["https://orcid.org/0000-0003-4785-2713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hristos Glavinas","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022023583","display_name":"Tam\u00e1s Solymosi","orcid":"https://orcid.org/0000-0003-2973-9696","observed_orcids":["https://orcid.org/0000-0003-2973-9696"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tam\u00e1s Solymosi","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009107739","display_name":"Zsolt \u00d6tv\u00f6s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zsolt Otvos","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019148445","display_name":"R\u00e9ka Angi","orcid":"https://orcid.org/0009-0001-8647-4615","observed_orcids":["https://orcid.org/0009-0001-8647-4615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R\u00e9ka Angi","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021577596","display_name":"Betti Ordasi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Betti Ordasi","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083624386","display_name":"Tam\u00e1s Jord\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tam\u00e1s Jord\u00e1n","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071142475","display_name":"L\u00e1szl\u00f3 Mil\u00e1n Moln\u00e1r","orcid":"https://orcid.org/0000-0003-4535-7292","observed_orcids":["https://orcid.org/0000-0003-4535-7292"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L\u00e1szl\u00f3 Moln\u00e1r","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"John McDermott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John McDermott","raw_affiliation_strings":["Quotient Sciences Ltd, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences Ltd, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083976305","display_name":"Vanessa Zann","orcid":"https://orcid.org/0000-0003-0747-181X","observed_orcids":["https://orcid.org/0000-0003-0747-181X"]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vanessa Zann","raw_affiliation_strings":["Quotient Sciences Ltd, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences Ltd, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110116626","display_name":"Ann Church","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ann Church","raw_affiliation_strings":["Quotient Sciences Ltd, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences Ltd, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108665685","display_name":"Stuart J. Mair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stuart Mair","raw_affiliation_strings":["Quotient Sciences Ltd, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences Ltd, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084790763","display_name":"Genov\u00e9va Filipcsei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Genoveva Filipcsei","raw_affiliation_strings":["NanGenex Inc., 1038 Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanGenex Inc., 1038 Budapest, Hungary;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073656213","display_name":"G\u00e1bor Heltovics","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabor Heltovics","raw_affiliation_strings":["Druggability Techologies Holdings Ltd., Swatar, Malta;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Druggability Techologies Holdings Ltd., Swatar, Malta;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"e17036","last_page":"e17036"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.826200008392334,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.826200008392334,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.08760000020265579,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":1.0},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9089999794960022},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.972000002861023},{"id":"https://openalex.org/keywords/dissolution","display_name":"dissolution","score":0.4180000126361847},{"id":"https://openalex.org/keywords/solubility","display_name":"solubility","score":0.7919999957084656},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8790000081062317},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.9210000038146973},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.9620000123977661},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7229999899864197},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.5600000023841858},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9013107419013977},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7619324922561646},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6972134709358215},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.6339705586433411},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5892614722251892},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.5781246423721313},{"id":"https://openalex.org/C2776421732","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone","level":5,"score":0.45973148941993713},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4412577450275421},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43621626496315},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.4226084351539612},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25153619050979614},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.10432982444763184},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10352760553359985},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.0},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.0},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.e17036","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e17036","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e17036","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2742217960","https://openalex.org/W4200405168","https://openalex.org/W3001519615","https://openalex.org/W2768693657","https://openalex.org/W2907514331","https://openalex.org/W4206439467","https://openalex.org/W2598829572","https://openalex.org/W4390399843","https://openalex.org/W7124737080","https://openalex.org/W4404839953"],"abstract_inverted_index":{"e17036":[0],"Background:":[1],"Zytiga":[2,60,76,91,236,261],"(Abiraterone":[3],"acetate,":[4],"AA)":[5],"is":[6,20,93,226],"known":[7],"to":[8,22,228,259],"exhibit":[9],"very":[10],"low":[11,111],"bioavailability":[12,112,309],"and":[13,25,53,113,125,130,135,166,173,185,249,299,305,314,319],"a":[14,102,118,218],"significant":[15,242,294,301],"positive":[16,243,302],"food":[17,62,114,244,303],"effect.":[18],"This":[19],"attributed":[21],"the":[23,29,32,36,65,73,78,110,160,170,177,193,206,223,230,238,250,266,307,322],"inadequate":[24],"variable":[26],"dissolution":[27,126],"of":[28,59,67,75,80,159,163,200,205,222,252,296,324],"compound":[30,207],"in":[31,35,64,100,105,137,145,169,176,237,265],"gastrointestinal":[33],"tract":[34],"fasted":[37,171,239],"state":[38,172],"(Geboers,":[39],"2016).":[40],"Recent":[41],"clinical":[42,133],"studies":[43],"show":[44],"that":[45],"abiraterone":[46,325],"trough":[47],"concentration":[48],"correlates":[49],"with":[50,61,122,183,208,272,293],"PSA":[51,68],"response":[52],"PFS":[54],"(Carton,":[55],"2015),":[56],"while":[57],"administration":[58],"resulted":[63],"reversal":[66],"progression":[69],"(Stover,":[70],"2015).":[71],"Doubling":[72],"dose":[74,221,291],"at":[77],"time":[79],"acquired":[81],"resistance":[82],"was":[83,143,181,246,254,269],"not":[84,94],"effective":[85],"(Friedlander,":[86],"2017)":[87,129],"most":[88],"likely":[89],"because":[90],"exposure":[92,232,253],"linear":[95],"above":[96],"1,000":[97,190,234],"mg":[98,168,175,191,220,235],"resulting":[99],"only":[101],"little":[103],"improvement":[104],"drug":[106,315],"exposure.":[107],"To":[108],"resolve":[109],"effect":[115,245],"we":[116],"developed":[117],"novel":[119,161,198,224,267,281],"AA":[120,164,201,263],"formulation":[121,162,199,225,268,282],"improved":[123,308],"solubility":[124],"characteristics":[127],"(Solymosi,":[128],"evaluated":[131],"its":[132],"pharmacokinetics":[134],"safety":[136,186,276],"healthy":[138,147],"volunteers.":[139],"Methods:":[140],"The":[141,197,241,280],"study":[142],"conducted":[144],"11":[146],"men":[148],"aged":[149],"47\u201357":[150],"years.":[151],"All":[152],"subjects":[153],"received":[154],"3":[155],"consecutive":[156],"single":[157],"doses":[158,313],"(100":[165],"200":[167,174],"fed":[178],"state).":[179],"Data":[180],"compared":[182,258],"pharmacokinetic":[184],"data":[187],"reported":[188],"for":[189,317],"Zytiga,":[192],"marketed":[194],"drug.":[195],"Results:":[196],"allows":[202,289],"rapid":[203],"absorption":[204],"tmax":[209],"values":[210],"within":[211],"one":[212],"hour.":[213],"Based":[214],"on":[215],"AUC":[216],"values,":[217],"~250":[219],"predicted":[227],"give":[229],"same":[231],"as":[233],"state.":[240],"also":[247],"eliminated":[248],"variability":[251,298],"significantly":[255],"reduced":[256],"when":[257],"published":[260],"data.":[262],"administered":[264],"well":[270],"tolerated":[271],"no":[273,300],"IMP":[274],"related":[275],"AEs":[277],"reported.":[278],"Conclusions:":[279],"has":[283],"two":[284],"potentially":[285],"advantageous":[286],"properties:":[287],"(1)":[288],"75%":[290],"reduction":[292,295],"inter-individual":[297],"effect,":[304],"(2)":[306],"could":[310],"allow":[311],"increased":[312],"exposures":[316],"patients":[318],"thereby":[320],"improve":[321],"outcome":[323],"acetate":[326],"therapy.":[327],"Clinical":[328],"trial":[329],"information:":[330],"2015-002759-83.":[331]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-09-27T00:00:00"}